Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium

Extraversion is a relatively stable and heritable personality trait associated with numerous psychosocial, lifestyle and health outcomes. Despite its substantial heritability, no genetic variants have been detected in previous genome-wide association (GWA) studies, which may be due to relatively small sample sizes of those studies. Here, we report on a large meta-analysis of GWA studies for extraversion in 63,030 subjects in 29 cohorts. Extraversion item data from multiple personality inventories were harmonized across inventories and cohorts. No genome-wide significant associations were found at the single nucleotide polymorphism (SNP) level but there was one significant hit at the gene level for a long non-coding RNA site (LOC101928162). Genome-wide complex trait analysis in two large cohorts showed that the additive variance explained by common SNPs was not significantly different from zero, but polygenic risk scores, weighted using linkage information, significantly predicted extraversion scores in an independent cohort. These results show that extraversion is a highly polygenic personality trait, with an architecture possibly different from other complex human traits, including other personality traits. Future studies are required to further determine which genetic variants, by what modes of gene action, constitute the heritable nature of extraversion

Design of a new recoil separator for measurements of radiative capture reactions in astrophysics

The rates of proton- and alpha-capture reactions on unstable proton-rich nuclei are needed to understand the energy generation and element synthesis occurring in novae, X-ray bursts, and other explosions. Direct measurements of the cross sections of some of these reactions are now possible with radioactive beams and a recoil separator. A new device for such measurements, the Separator for CApture Reactions [SECAR], is being designed for use at the Facility for Rare Isotope Beams (FRIB). The specifications and preliminary conceptual design will be discussed along with plans for the first set of measurements. © 2010 American Institute of Physics

First pionic atom spectroscopy at RIBF

We have performed an inclusive spectroscopy of 122Sn(d, 3He) reaction near the pion emission threshold at an incident energy of Td = 250 MeV/nucleon. The first experiment aims as devloping the high precision spectroscopy of pionic atoms at the RI beam factory (RIBF) of RIKEN, which leads to a new project, pionic Atom Factory project (piAF) to measure pionic atoms for a wide range of elements. We report the analysis status of the pilot experiment

First pionic atom spectroscopy at RIBF

We have performed an inclusive spectroscopy of 122Sn(d, 3He) reaction near the pion emission threshold at an incident energy of Td = 250 MeV/nucleon. The first experiment aims as devloping the high precision spectroscopy of pionic atoms at the RI beam factory (RIBF) of RIKEN, which leads to a new project, pionic Atom Factory project (piAF) to measure pionic atoms for a wide range of elements. We report the analysis status of the pilot experiment

Precision spectroscopy of pionic atoms and chiral symmetry in nuclei

We conduct an experimental project to make spectroscopy of deeply bound pionic atoms systematically over wide range of nuclei. We aim at studying the strong interaction in the low energy region, which has close connection to spontaneous chiral symmetry breaking and its partial restoration in nuclear matter. First experimental results show improved spectral resolution and much better statistical sensitivity than previous experiments. Present status of the experiment is reported

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

We have previously shown higher-than-expected rates of schizophrenia in relatives of patients with amyotrophic lateral sclerosis (ALS), suggesting an aetiological relationship between the diseases. Here, we investigate the genetic relationship between ALS and schizophrenia using genome-wide association study data from over 100,000 unique individuals. Using linkage disequilibrium score regression, we estimate the genetic correlation between ALS and schizophrenia to be 14.3% (7.05-21.6; P=1 × 10) with schizophrenia polygenic risk scores explaining up to 0.12% of the variance in ALS (P=8.4 × 10). A modest increase in comorbidity of ALS and schizophrenia is expected given these findings (odds ratio 1.08-1.26) but this would require very large studies to observe epidemiologically. We identify five potential novel ALS-associated loci using conditional false discovery rate analysis. It is likely that shared neurobiological mechanisms between these two disorders will engender novel hypotheses in future preclinical and clinical studies

Meta-analysis of genome-wide association studies for neuroticism, and the polygenic association with major depressive disorder

IMPORTANCE Neuroticism is a pervasive risk factor for psychiatric conditions. It genetically overlaps with major depressive disorder (MDD) and is therefore an important phenotype for psychiatric genetics. The Genetics of Personality Consortium has created a resource for genome-wide association analyses of personality traits in more than 63 000 participants (including MDD cases). OBJECTIVES To identify genetic variants associated with neuroticism by performing a meta-analysis of genome-wide association results based on 1000 Genomes imputation; to evaluate whether common genetic variants as assessed by single-nucleotide polymorphisms (SNPs) explain variation in neuroticism by estimating SNP-based heritability; and to examine whether SNPs that predict neuroticism also predict MDD. DESIGN, SETTING, AND PARTICIPANTS Genome-wide association meta-analysis of 30 cohorts with genome-wide genotype, personality, and MDD data from the Genetics of Personality Consortium. The study included 63 661 participants from 29 discovery cohorts and 9786 participants from a replication cohort. Participants came from Europe, the United States, or Australia. Analyses were conducted between 2012 and 2014. MAIN OUTCOMES AND MEASURES Neuroticism scores harmonized across all 29 discovery cohorts by item response theory analysis, and clinical MDD case-control status in 2 of the cohorts. RESULTS A genome-wide significant SNP was found on 3p14 in MAGI1 (rs35855737; P = 9.26 × 10-9 in the discovery meta-analysis). This association was not replicated (P = .32), but the SNP was still genome-wide significant in the meta-analysis of all 30 cohorts (P = 2.38 × 10-8). Common genetic variants explain 15%of the variance in neuroticism. Polygenic scores based on the meta-analysis of neuroticism in 27 cohorts significantly predicted neuroticism (1.09 × 10-12 -9 < P < .05) in the 2 other cohorts. CONCLUSIONS AND RELEVANCE This study identifies a novel locus for neuroticism. The variant is located in a known gene that has been associated with bipolar disorder and schizophrenia in previous studies. In addition, the study shows that neuroticism is influenced by many genetic variants of small effect that are either common or tagge